Cell-specific adenovirus vector comprising EBV-specific...

Details Cell-specific adenovirus vector comprising EBV-specific... Cell-specific adenovirus vector comprising EBV-specific...

2008-05-13

2008-05-13

Guzo, David (Department: 1636)

Chemistry: molecular biology and microbiology

Vector, per se

C435S325000, C536S023100, C536S024100

Reexamination Certificate

active

07371570

ABSTRACT:
Replication-competent adenoviral vectors comprising an EBV-specific transcriptional regulatory element (TRE) operably linked to a gene required for adenovirus replication are provided. By providing for transcriptional initiating regulation dependent upon transcription factors that are only active in specific, limited cell types, virus replication can be restricted to particular target cells. The modified adenovirus may be used as a vehicle for introducing new genetic capability, particularly associated with cytotoxicity for treating neoplasia.

REFERENCES:
patent: 5998205 (1999-12-01), Hallenbeck et
patent: 6432700 (2002-08-01), Henderson et
patent: 6551587 (2003-04-01), Hallenbeck et
patent: 6638762 (2003-10-01), Chang et al.
patent: 6692736 (2004-02-01), Yu et al.
patent: 2001/0006633 (2001-07-01), Kirn
patent: 2001/0053768 (2001-12-01), Gregory et al.
patent: 2003/0026789 (2003-02-01), Gregory et al.
patent: 2003/0068307 (2003-04-01), Yu et al.
patent: 2003/0104625 (2003-06-01), Cheng et al.
patent: 2004/0009588 (2004-01-01), Chang et al.
patent: WO 92/03563 (1992-03-01), None
patent: WO 96/17053 (1996-06-01), None
patent: WO 98/29555 (1998-07-01), None
patent: WO 98/39464 (1998-09-01), None
patent: WO 96/34969 (1998-11-01), None
patent: WO 99/25860 (1999-05-01), None
patent: WO 99/28469 (1999-06-01), None
patent: WO 99/58604 (1999-11-01), None
patent: WO 01/36650 (2001-05-01), None
patent: WO 01/72341 (2001-10-01), None
patent: WO 01/73093 (2001-10-01), None
patent: WO 02/067861 (2002-09-01), None
Chen et al., Linkage Between Stat Regulation and Epstein-Barr Virus Gene Expression in Tumors, J. Virol., 2001, 75(6): 2929-2937.
Chia et al., A Novel Conditionally Oncolytic Adenovirus for the Treatment of Nasopharyngeal Carcinoma (NPC), Proc. Amer. Ass. For Cancer Res., 2002, 43: 1098-1099.
Chiocca et al., Oncolytic Viruses, Nature Publishing Group, 2002, 2: 938-951.
Feng et al., Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 to Treat EBV-Positive Tumors, J Virol., 2002, 76(21):10951-10959.
Grinstein et al., Demonstration of Epstein-Barr Virus in Carcinomas of Various Sites, Cancer Res., 2002, 1:62(17):4876-4878.
Li et al., Tumor-Targeted Gene Therapy for Nasopharyngeal Carcinoma, Cancer Res., 2002, 62: 171-178.
Reisman et al., Trans Activation of an Epstein-Barr Viral Transcriptional Enhancer by the Epstein-Barr Viral Nuclear Antigen 1, Molecular and Cell. Biol., 1986, 6(11): 3838-3846.
Sadler et al., The Epstein-Barr Virus 3.5-Kilobase Latent Membrane Protein 1 MRNA Initiates From a Tata-Less Promoter Within the First Terminal Repeat, J. of Virol., 1995, 69(7): 4577-4581.
Sjöblom et al., An ATF/CRE Element Mediates Both EBNA2-Dependent and EBNA2-Independent Activation of the Epstein-Barr Virus LMP1 Gene Promoter, J. of Virol., 1998, 72(2): 1365-1376.
Tsai et al., Additive Effect of SP1 and SP3 in Regulation of the ED-L1E Promoter of the EBV LMP 1 Gene in Human Epithelial Cells, Virology, 1999, 261: 288-294.
Yu et al., Selectively Replicating Oncolytic Adenoviruses as Cancer Therapeutics, Curr. Opinion in Mol. Ther., 2002, 4(5): 435-443.
Waehler et al., Experimental Gene Therapy of Hepatocellular Carcinoma: Expression of IL-12, 4-1BBL and IL-2 From a Single Adenoviral Vector, 10thAnnual ESGT meeting, Oct. 13-16, 2002.

Affiliated with

Also associated with

Rating

Cell-specific adenovirus vector comprising EBV-specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell-specific adenovirus vector comprising EBV-specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell-specific adenovirus vector comprising EBV-specific... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2751439